Intensive Care in General Clinical Trial
Official title:
Development of a Biological Database in the Field of Operative Intensive Care for the Recording of Clinically Relevant Parameters of Critically Ill Intensive Patients
The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.
The storage and use of biomaterial samples is an important requirement for accompanying
research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is
explicitly recommended in official guidelines. In order to preserve the biomaterial, the
patient must consent to the removal, transfer and storage of the biomaterial separately from
the consent to the register. The biomaterial is taken at times at which a blood or urine
sampling takes place anyway in the clinical routine. Therefore no additional interventions
are necessary.
Sample volumes are defined as follows:
- Peripheral blood: up to a total of 150 ml distributed to a maximum of 10 morning blood
samples (approximately 15 ml blood per blood sample) during the inpatient stay in the
intensive care unit (fixed times are admission and discharge of the intensive care unit)
- Urine: a total of up to 200 ml of catheter urine distributed to a maximum of 10 morning
withdrawals during inpatient stays in the intensive care unit (defined times are
admission and discharge from the intensive care unit)
;